Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications

Journal of Medicinal Food

Volumn 16, Issue 5, 2013, Pages 375-382

  Bahadoran, Zahra ^a   Mirmiran, Parvin ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

broccoli sprouts; diabetes complications; insulin resistance; oxidative stress; sulforaphane

Indexed keywords

C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; SULFORAPHANE; TRIACYLGLYCEROL;

ANTIOXIDANT ACTIVITY; BROCCOLI; CANCER PREVENTION; CHOLESTEROL BLOOD LEVEL; DIABETIC NEPHROPATHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BRASSICA; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 84877844387     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2559     Document Type: Review

References (86)

1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622.
2. Goycheva V, Gadjeva B: Popov: oxidative stress and its complications in diabetes mellitus. Trakia J Sci 2006;4:1-8.
3. Santaguida PL, Balion C, Hunt D: Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess 2008;12:1-11.
4. Dämon S, Schätzer M, Höfler J, Tomasec G, Hoppichler F: Nutrition and diabetes mellitus: an overview of the current evidence. Wien Med Wochenschr 2011;161:282-288.
5. Carvajal M, Berenguer C, Viguera C: Chemical and biological characterisation of nutraceutical compounds of broccoli. J Pharma Biomed Anal 2006;41:1508-1522.
6. Jeffery E, Araya M: Physiological effects of broccoli consumption. Phytochem Rev 2009;8:283-298.
7. Wu L, Noyan Ashraf MH, Facci M, et al.: Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci USA 2004; 101:7094-7099.
8. Lee J, Shin H, Lee Y, Kim A, Lee M: Effect of Broccoli sprouts on cholesterol-lowering and anti-obesity effects in rats fed high fat diet. J Korean Soc Food Sci Nutr 2009;38:309-318.
9. Keum Y, Jeong W, Kong T: Chemoprevention by isothio-cyanates and underlying molecular signaling mechanisms. Mutat Res 2004;555:191-202.
10. Verkerk R, Schreiner M, Krumbein A: Glucosinolates in brassica vegetable: the influence of the food supply chain on intake, bioavailability and human health. Mol Nutr Food Res 2009;53: S219-S266.
11. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ: Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyper-glycemia linked to vascular disease. Diabetes 2008;57:2809-2817.
12. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y: Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 2008;8:115-125.
13. Piao XL, Kim HY, Yokozawa T, Lee YA, Piao XS, Cho EJ: Protective effects of broccoli (Brassica oleracea) and its active components against radical-induced oxidative damage. J Nutr Sci Vitaminol 2005;51:142-147.
14. Riedl MA, Saxon A, Diaz-Sanchez D: Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009;130:244-251.
15. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C: Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 2001;276:32008-32015.
16. Mukherjee S, Gangopadhyay H, Das DK: Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem 2008;56:609-617.
17. Fahey JW, Haristoy X, Dolan PM, et al.: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 2002;99:7610-7615.
18. Han JM, Lee YJ, Lee SY, et al.: Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 2007; 321:249-256.
19. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH: Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 2006;20:506-508.
20. Hu R, Xu C, Shen G, et al.: Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 2006;243:170-192.
21. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
22. Opara EC, Abdel-Rahman E, Soliman S: Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999;48: 1414-1417.
23. Pérez-Matute P, Zulet MA, Martínez JA: Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol 2009;9:771-779.
24. Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17: 24-38.
25. Boddupalli S, Mein JR, Lakkanna S, James DR: Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E. Front Genet 2012;3:7.
26. Evcimen ND, King GL: The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007;55:498-510.
27. Wright E Jr, Scism-Bacon JL, Glass LC: Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308-314.
28. Cho EJ, Lee YA, Yoo HH, Yokozawa T: Protective effects of broccoli (Brassica oleracea) against oxidative damage in vitro and in vivo. J Nutr Sci Vitaminol (Tokyo) 2006;52:437-444.
29. Bahadoran Z, Mirmiran P, Hosseinpanah F, Hedayati M, Hos-seinpour-Niazi S, Azizi F: Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. Eur J Clin Nutr 2011;65:972-977.
30. Murashima M, Watanabe S, Zhuo XG, Uehara M, Kurashige A: Phase 1 study of multiple biomarkers for metabolism and oxi-dative stress after one-week intake of broccoli sprouts. Biofactors 2004;22:271-275.
31. Kaspar JW, Niture SK, Jaiswal AK: Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009;47: 1304-1309.
32. Hybertson BM, Gao B, Bose SK, McCord JM: Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 2011;32:234-246.
33. Spranger J, Kroke A, Möhlig M, et al.: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-817.
34. King GL: The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527-1534.
35. Sjöholm A, Nyström T: Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4-10.
36. Goldberg RB: Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94:3171-3182.
37. Abdin AA, Baalash AA, Hamooda HE: Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complications 2010;24:168-178.
38. Ritz SA, Wan J, Diaz-Sanchez D: Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am J Physiol Lung Cell Mol Physiol 2007;292:L33-L39.
39. Shan Y, Zhao R, Geng W, et al.: Protective effect of sulfor-aphane on human vascular endothelial cells against lipopoly-saccharide-induced inflammatory damage. Cardiovasc Toxicol 2010;10:139-145.
40. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN: Sulfor-aphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 2008;76:967-973.
41. Mirmiran P, Bahadoran Z, Hosseinpanah Z, Keyzad A, Azizi F: Effects of broccoli sprouts with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. J Funct Foods 2012;4:837-841.
42. Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, et al.: Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian J Exp Biol 2004;42:341-353.
43. Lebovitz HE: Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109:S135-S148.
44. Henriksen EJ, Diamond-Stanic MK, Marchionne EM: Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2001;51:993-999.
45. Hoehn KL, Salmon AB, Hohnen-Behrens C, et al.: Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci USA 2009;106:17787-17792.
46. Park K, Gross M, Lee DH, et al.: Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care 2009;32:1302-1307.
47. Evans JL: Antioxidants: do they have a role in the treatment of insulin resistance? Indian J Med Res 2007;125:355-372.
48. Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P: Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial. Int J Food Sci Nutr 2012;63:767-761.
49. Patel S, Santani D: Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 2009; 61:595-603.
50. Haluzík MM, Haluzík M: PPAR-alpha and insulin sensitivity. Physiol Res 2006;55:115-122.
51. Nicolucci A, De Berardis G, Sacco M, Tognoni G: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30:162-172.
52. Bahadoran Z, Mirmiran P, Hosseinpanah F, Rajab A, Asghari G, Azizi F: Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Diabetes Res Clin Pract 2012;96:348-354.
53. Christiansen B, Bellostas Muguerza N, Petersen AM, et al.: Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension. PLoS One 2010;5:e12461.
54. Kahlon TS, Chapman MH, Smith GE: In vitro binding of bile acids by spinach, kale, brusseles sprouts, broccoli, mustard green, green bell pepper, cabbage and collards. Food Chem 2007;100: 1531-1536.
55. Dunn SE, LeBlanc GA: Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivatives. Biochem Pharmacol 1994;47: 359-364.
56. Maiyoh GK, Kuh JE, Casaschi A, Theriault AG: Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cells. J Nutr 2007;137:2185-2189.
57. Huang J, Tabbi-Anneni I, Gunda V, Wang L: Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol 2010;299:G1211-1221.
58. Tavares V, Hirata MH, Hirata RD: Peroxisome proliferator-activated receptor gamma (PPARgamma): molecular study in glucose homeostasis, lipid metabolism and therapeutic. Arq Bras Endocrinol Metabol 2007;51:526-533.
59. Marrollo M, Latella G, Melideo D, et al.: Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001;33:21-29.
60. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U: Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 2008;53:2646-2649.
61. Hamed SA, Amine NF, Galal GM, et al.: Vascular risks and complications in diabetes mellitus. the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008;17:86-94.
62. Tanriverd O: Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients. Turk J Gastro-enterol 2011;22:569-574.
63. Wang SZ, Shi YN, Zhao J, Wang ZD: Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009;89:958-961.
64. Galan MV, Kishan AA, Silverman AL: Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dis Dig Sci 2004;49:1088-1090.
65. Yanaka A, Fahey JW, Fukumoto A, et al.: Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila) 2009;2:353-360.
66. Putnam W, Buhariwalla F, Lacey K, et al.: Drug management for hypertension in type 2 diabetes in family practice. Can Fam Physician 2009;55:728-734.
67. Jesmin J, Rashid MS, Jamil H, Hontecillas R, Bassaganya-Riera J: Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension. BMC Med Genomics 2010;3:45.
68. Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG; Diabetes and Cancer Research Consortium: Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 2012;55:1607-1618.
69. Cannata D, Fierz Y, Vijayakumar A, LeRoith D: Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 2010;77: 197-213.
70. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer 2009;16:1103-1123.
71. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P: Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev 2001;10:501-508.
72. James D, Devaraj S, Bellur P, Lakkanna S, Vicini J, Boddupalli S: Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli. Nutr Rev 2012;70:654-665.
73. Gamet-Payrastre L, Li P, Lumeau S, et al.: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000; 60:1426-1433.
74. Pledgie-Tracy A, Sobolewski MD, Davidson NE: Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007;6:1013-1021.
75. Valk EJ, Bruijn JA, Bajema IM: Diabetic nephropathy in humans: pathologic diversity. Curr Opin Nephrol Hypertens 2011;20:285-289.
76. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 2010;17:4256-4269.
77. Li B, Liu S, Miao L, Cai L: Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp Diabetes Res 2012;2012:216512.
78. Zheng H, Whitman SA, Wu W, et al.: Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011;60:3055-3066.
79. Cui W, Bai Y, Miao X, et al.: Prevention of diabetic nephropathy by sulforaphane: possible role of nrf2 upregulation and activation. Oxid Med Cell Longev 2012;2012:821936.
80. Creager MA, Lüscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003;108:1527-1532.
81. Endemann DH, Schiffrin EL: Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 2004;6:85-89.
82. Zakkar M, Van der Heiden K, Luong le A, Chaudhury H, Cuhlmann S, Hamdulay SS: Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 2009;29:1851-1857.
83. Miao X, Bai Y, Sun W, et al.: Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutr Metab (Lond) 2012;9:84.
84. Ha H, Kim KH: Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 1999;45:147-151.
85. Chiang DJ, Pritchard MT, Nagy LE: Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2011;300:G697-G702.
86. Oh CJ, Kim JY, Min AK, et al.: Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-b/Smad signaling. Free Radic Biol Med 2012;52:671-682.